United States · Series C startup

Who invested in Eureka Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$21Mraised across 1 round since 2014, from 1 source

Latest round
Series C, $21MSept 2014
Investors
5
See who backed them

The rounds

  1. Sept 2014
    Series C$21M

    From a historical funding recordSEC filing: $21M sold, first sale Aug 2014

Founders and team

From Eureka Therapeutics's own website and the SEC filings it signed: 9 on the team.

  • Victor S. ShumSenior Vice President, Clinical Development and CMC
  • Alexa WillsonCFO
  • Sandy ChauDirector
  • Cheng LiuExecutive Officer, Directori
  • Chih-Kai ""C.K."" D. ChengDirector
  • Jacqueline S. NorthcutDirector
  • Marvin T. SamsonDirector
  • Michael D. CannonDirector
  • Vivien S. ChanExecutive Officeri

On the board, as filediBo D. FengWai-Yan ""Sandy"" D. ChauWilliam S. Solari

AdvisersReginald Seeto

Everyone who backed them

MajuvenVC firm1round
Yuan CapitalGrowth equity1round
Acorn CampusGrowth equity1round
Harbinger Venture Capitalno record of our own yet1round
Suma Ventureno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Eureka Therapeutics

Who invested in Eureka Therapeutics?

Eureka Therapeutics's investors include Majuven, Yuan Capital, Acorn Campus, Harbinger Venture Capital and Suma Venture.

How much has Eureka Therapeutics raised?

Eureka Therapeutics has raised $21M across 1 round since 2014.

When did Eureka Therapeutics last raise?

Eureka Therapeutics's most recent round was a Series C of $21M in Sept 2014.

What was Eureka Therapeutics's biggest round?

Its most recent round, $21M in Sept 2014, is also its largest on record.

Who backed Eureka Therapeutics first?

Eureka Therapeutics's first round on record, in Sept 2014, was backed by Majuven, Yuan Capital and Acorn Campus and 2 others.

What stage is Eureka Therapeutics at?

Eureka Therapeutics's latest named round is a Series C, in Sept 2014.

Where is Eureka Therapeutics based?

Eureka Therapeutics is based in the United States.

Companies like Eureka Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.